With armies of lawyers on both sides, this one's a biggie. Monsanto is out to an early lead with a partial summary judgment on its contract claims. But with Dupont's antitrust and patent fraud allegations still to be heard, the case has a long way to go.

Drug pricing antitrust suits against pharma companies are a dime a dozen. But what we can't remember seeing before at the Litigation Daily is a case in which one major brand pharmaceutical manufacturer is going to trial against another for alleged drug overcharges. The stakes are enormous--potential trebled damages of $9.8 billion--and the legal teams formidable.

Is your head spinning yet? O'Melveny & Myers claims Gucci can't claim privilege over communications with an in-house lawyer who turned out not to be licensed to practice. But the expert we consulted says O'Melveny's argument is rubbish.

Sprint Nextel's lawyers at Skadden, Arps, Slate, Meagher & Flom have been airing the company's antitrust misgivings about the proposed AT&T acquisition since May. On Tuesday, just a week after the Department of Justice sued to block the deal, Sprint is upping the ante with a Washington, D.C., federal district court suit that it wants consolidated with the government's case.